EuCorVac-19

EuCorVac-19 er en covid-19-vaksinekandidat som er blitt utviklet av EuBiologics Co.[1][2][3][4][5]

Referanser

  1. ^ «Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults». clinicaltrials.gov. United States National Library of Medicine. Besøkt 20. mars 2021. 
  2. ^ «EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea». Business Wire. 21. januar 2021. 
  3. ^ «EuBiologics Wins Approval on Clinical Trial of COVID-19 Vaccine 'EuCOVAC-19'». Business Korea. 21. januar 2021. 
  4. ^ «EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea». EuBiologics. 21. januar 2021. 
  5. ^ «Firm looks to build vaccine manufacturing plant in PH». ABS-CBN News (engelsk). 12. april 2021.